James Joseph Martin - Net Worth and Insider Trading

James Joseph Martin Net Worth

The estimated net worth of James Joseph Martin is at least $31,839 dollars as of 2024-11-29. James Joseph Martin is the Director of PetVivo Holdings Inc and owns about 67,384 shares of PetVivo Holdings Inc (PETV) stock worth over $31,839. Details can be seen in James Joseph Martin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Joseph Martin has not made any transactions after 2021-04-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of James Joseph Martin

James Joseph Martin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Joseph Martin owns 6 companies in total, including Cocrystal Pharma Inc (COCP) , Healthier Choices Management Corp (HCMC) , and Non-Invasive Monitoring Systems Inc (NIMU) among others .

Click here to see the complete history of James Joseph Martin’s form 4 insider trades.

Insider Ownership Summary of James Joseph Martin

Ticker	Comapny	Transaction Date	Type of Owner
COCP	Cocrystal Pharma Inc	2017-02-23	Interim CFO
HCMC	Healthier Choices Management Corp	2015-03-04	Chief Financial Officer
NIMU	Non-Invasive Monitoring Systems Inc	2011-01-10	Chief Financial Officer
		2011-01-10	Chief Financial Officer
		2021-04-24	director
		2021-01-11	director

James Joseph Martin Latest Holdings Summary

James Joseph Martin currently owns a total of 1 stock. James Joseph Martin owns 67,384 shares of PetVivo Holdings Inc (PETV) as of April 24, 2021, with a value of $31,839.

Latest Holdings of James Joseph Martin

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PETV	PetVivo Holdings Inc	2021-04-24	67,384	0.47	31,839

Holding Weightings of James Joseph Martin

James Joseph Martin Form 4 Trading Tracker

According to the SEC Form 4 filings, James Joseph Martin has made a total of 1 transactions in PetVivo Holdings Inc (PETV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PetVivo Holdings Inc is the acquisition of 3,000 shares on April 24, 2021, which cost James Joseph Martin around $21,000.

Insider Trading History of James Joseph Martin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Joseph Martin Trading Performance

GuruFocus tracks the stock performance after each of James Joseph Martin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Joseph Martin is -21.46%. GuruFocus also compares James Joseph Martin's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Joseph Martin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Joseph Martin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Joseph Martin

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-1.46
Relative Return to S&P 500(%)	-1.86

James Joseph Martin Ownership Network

Ownership Network List of James Joseph Martin

No Data

Ownership Network Relation of James Joseph Martin

James Joseph Martin Owned Company Details

What does Cocrystal Pharma Inc do?

Who are the key executives at Cocrystal Pharma Inc?

James Joseph Martin is the Interim CFO of Cocrystal Pharma Inc. Other key executives at Cocrystal Pharma Inc include director & 10 percent owner Frost Phillip Md Et Al , director & 10 percent owner Raymond F Schinazi , and INTERIM CFO Curtis Dale .

Cocrystal Pharma Inc (COCP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cocrystal Pharma Inc (COCP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cocrystal Pharma Inc (COCP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cocrystal Pharma Inc (COCP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cocrystal Pharma Inc Insider Transactions

No Available Data

What does Healthier Choices Management Corp do?

Who are the key executives at Healthier Choices Management Corp?

James Joseph Martin is the Chief Financial Officer of Healthier Choices Management Corp. Other key executives at Healthier Choices Management Corp include Chief Executive Officer Jeffrey Elliot Holman , President and COO Christopher Santi , and Chief Financial Officer John Ollet .

Healthier Choices Management Corp (HCMC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Healthier Choices Management Corp (HCMC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Healthier Choices Management Corp (HCMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Healthier Choices Management Corp (HCMC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Healthier Choices Management Corp Insider Transactions

No Available Data

What does Non-Invasive Monitoring Systems Inc do?

Who are the key executives at Non-Invasive Monitoring Systems Inc?

James Joseph Martin is the Chief Financial Officer of Non-Invasive Monitoring Systems Inc. Other key executives at Non-Invasive Monitoring Systems Inc include 10 percent owner Frost Phillip Md Et Al , director & 10 percent owner Hsiao Jane Ph D , and director & 10 percent owner & CEO Marvin Arthur Sackner .

Non-Invasive Monitoring Systems Inc (NIMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Non-Invasive Monitoring Systems Inc (NIMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Non-Invasive Monitoring Systems Inc (NIMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Non-Invasive Monitoring Systems Inc (NIMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Non-Invasive Monitoring Systems Inc Insider Transactions

No Available Data

What does Asensus Surgical Inc do?

Who are the key executives at Asensus Surgical Inc?

James Joseph Martin is the Chief Financial Officer of Asensus Surgical Inc. Other key executives at Asensus Surgical Inc include Chief Technology Officer Fernando Anthony C. J. , EVP & Chief Financial Officer Rampertab Shameze , and Interim CFO Brett Farabaugh .

Asensus Surgical Inc (ASXC) Insider Trades Summary

Over the past 18 months, James Joseph Martin made no insider transaction in Asensus Surgical Inc (ASXC). Other recent insider transactions involving Asensus Surgical Inc (ASXC) include a net sale of 0 shares made by Starling William N Jr ,

In summary, during the past 3 months, insiders sold 0 shares of Asensus Surgical Inc (ASXC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,134 shares of Asensus Surgical Inc (ASXC) were sold and 18,134 shares were bought by its insiders, resulting in a net sale of 0 shares.

Asensus Surgical Inc (ASXC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Asensus Surgical Inc Insider Transactions

No Available Data

What does PetVivo Holdings Inc do?

Who are the key executives at PetVivo Holdings Inc?

James Joseph Martin is the director of PetVivo Holdings Inc. Other key executives at PetVivo Holdings Inc include director & 10 percent owner & CEO John Lai , 10 percent owner A.l. Sarroff Fund, Llc , and Chief Financial Officer Robert J. Folkes .

PetVivo Holdings Inc (PETV) Insider Trades Summary

Over the past 18 months, James Joseph Martin made no insider transaction in PetVivo Holdings Inc (PETV). Other recent insider transactions involving PetVivo Holdings Inc (PETV) include a net purchase of 150,000 shares made by John Lai , and a net purchase of 22,224 shares made by James Rudolph Martin .

In summary, during the past 3 months, insiders sold 0 shares of PetVivo Holdings Inc (PETV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PetVivo Holdings Inc (PETV) were sold and 172,224 shares were bought by its insiders, resulting in a net purchase of 172,224 shares.

PetVivo Holdings Inc (PETV)'s detailed insider trading history can be found in Insider Trading Tracker table.

PetVivo Holdings Inc Insider Transactions

No Available Data

What does SAB Biotherapeutics Inc do?

Who are the key executives at SAB Biotherapeutics Inc?

James Joseph Martin is the director of SAB Biotherapeutics Inc. Other key executives at SAB Biotherapeutics Inc include director & 10 percent owner & Chief Executive Officer Eddie Joe Sullivan , CHIEF FINANCIAL OFFICER Michael King , and director & Executive Chairman Samuel J Reich .

SAB Biotherapeutics Inc (SABS) Insider Trades Summary

Over the past 18 months, James Joseph Martin made no insider transaction in SAB Biotherapeutics Inc (SABS). Other recent insider transactions involving SAB Biotherapeutics Inc (SABS) include a net purchase of 11,000 shares made by Samuel J Reich , a net purchase of 5,000 shares made by Michael King , and a net purchase of 1,740 shares made by Eddie Joe Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of SAB Biotherapeutics Inc (SABS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SAB Biotherapeutics Inc (SABS) were sold and 1,774 shares were bought by its insiders, resulting in a net purchase of 1,774 shares.

SAB Biotherapeutics Inc (SABS)'s detailed insider trading history can be found in Insider Trading Tracker table.

SAB Biotherapeutics Inc Insider Transactions

No Available Data

James Joseph Martin Mailing Address

Above is the net worth, insider trading, and ownership report for James Joseph Martin. You might contact James Joseph Martin via mailing address: 4400 Biscayne Blvd, Suite # 670, Miami Fl 33157.

Discussions on James Joseph Martin

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.